Search

Your search keyword '"Joseph J. Skitzki"' showing total 128 results

Search Constraints

Start Over You searched for: Author "Joseph J. Skitzki" Remove constraint Author: "Joseph J. Skitzki"
128 results on '"Joseph J. Skitzki"'

Search Results

2. Manipulating adrenergic stress receptor signaling to enhance immunosuppression and prolong survival of vascularized composite tissue transplants

3. A pilot trial of intravital microscopy in the study of the tumor vasculature of patients with peritoneal carcinomatosis

4. Intraoperative intravital microscopy permits the study of human tumour vessels

5. Improved Cuff Technique and Intraoperative Detection of Vascular Complications for Hind Limb Transplantation in Mice

6. Homogenous Good Outcome in a Heterogeneous Group of Tumors: An Institutional Series of Outcomes of Superficial Soft Tissue Sarcomas

7. Gynecomastia-Like Hyperplasia of Axillary Ectopic Breast Tissue in a Young Female

8. Supplementary Figure S2 from Neoadjuvant Pembrolizumab and High-Dose IFNα-2b in Resectable Regionally Advanced Melanoma

9. Supplementary figure legend 1 from Neoadjuvant Pembrolizumab and High-Dose IFNα-2b in Resectable Regionally Advanced Melanoma

10. Supplementary figure legend 2 from Neoadjuvant Pembrolizumab and High-Dose IFNα-2b in Resectable Regionally Advanced Melanoma

11. Data from Neoadjuvant Pembrolizumab and High-Dose IFNα-2b in Resectable Regionally Advanced Melanoma

12. Recombinant human Hsp110-gp100 chaperone complex vaccine is nontoxic and induces response in advanced stage melanoma patients

13. Barriers to Referral for Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Identified Using a Tailoring Grid Methodology: Interviews with Stakeholders in New York State

14. Restrictive Intraoperative Fluid Rate is Associated with Improved Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

15. NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021

16. Neoadjuvant Pembrolizumab and High-Dose IFNα-2b in Resectable Regionally Advanced Melanoma

17. Dynamic control of tumor vasculature improves antitumor responses in a regional model of melanoma

18. A Translational Hepatic Artery Infusion (HAI) Model for Hepatocellular Carcinoma in Woodchucks

19. Surgical Management of Primary Cutaneous Melanoma

20. Manipulating Stress Receptor Signaling to Enhance Immunosuppression and Prolong Survival of Vascularized Composite Tissue

21. Outcomes After Adjuvant Hyperthermic Intraperitoneal Chemotherapy for High-Risk Primary Appendiceal Neoplasms After Complete Resection

22. Tertiary Lymphoid Structures as Mediators of Immunotherapy Response

23. ASO Visual Abstract: Restrictive Intraoperative Fluid Rate Is Associated with Improved Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

24. Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery Committee

26. Intra-arterial Versus Intravenous Adoptive Cell Therapy in a Mouse Tumor Model

27. Intravital microscopy in the study of the tumor microenvironment: from bench to human application

28. Conditional Survival-Based 'Abbreviated' Routine Cancer Surveillance for Pathologic Stage IB Melanoma

29. Novel mouse models of hepatic artery infusion

30. Water lavage as an adjunct to cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC)

31. Cytoreduction and hyperthermic intraperitoneal chemotherapy (CS/HIPEC) in colorectal cancer: Evidence-based review of patient selection and treatment algorithms

32. Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

33. 77286 Intravital microscopy in the study of the tumor vasculature of patients with peritoneal carcinomatosis

34. Systemic Therapy in Advanced Cutaneous Squamous Cell Carcinoma (CSCC)

35. Current Delivery of Hyperthermic Intraperitoneal Chemotherapy with Cytoreductive Surgery (CS/HIPEC) and Perioperative Practices: An International Survey of High-Volume Surgeons

36. NCCN Guidelines Insights: Melanoma, Version 3.2016

37. Melanoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology

38. Intraoperative intravital microscopy permits the study of human tumour vessels

39. Abstract LB-396: Amplification of the CXCR3/CXCL9 axis via intratumoral electroporation of CXCL9 synergizes with IL-12 gene therapy (TAVO) to elicit robust anti-tumor immunity

40. Malignant adnexal tumors of the skin: a single institution experience

41. Improved Cuff Technique and Intraoperative Detection of Vascular Complications for Hind Limb Transplantation in Mice

42. real time observation of tumor-host interaction during ovarian cancer cytoreductive surgery using intravital microsocopy

43. A murine model of targeted infusion for intracranial tumors

44. The Role of Regional Therapies for in-Transit Melanoma in the Era of Improved Systemic Options

45. Key gaps in pathologic reporting for appendiceal mucinous neoplasms: time for universal synoptic reporting?

46. A phase I study of neoadjuvant combination immunotherapy in locally/regionally advanced melanoma

47. MLN2238, a proteasome inhibitor, induces caspase-dependent cell death, cell cycle arrest, and potentiates the cytotoxic activity of chemotherapy agents in rituximab-chemotherapy-sensitive or rituximab-chemotherapy-resistant B-cell lymphoma preclinical models

48. Targeting the Heat Shock Response in Cancer

49. Consensus Guidelines from The American Society of Peritoneal Surface Malignancies on Standardizing the Delivery of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer Patients in the United States

50. The benefit of intraperitoneal chemotherapy for the treatment of colorectal carcinomatosis

Catalog

Books, media, physical & digital resources